Taisie Seigrist, a 15-year-old track and cross-country athlete in Oklahoma, was diagnosed with Type 1 diabetes five years ago ...

MannKind posted Phase 3 trial results last October, comparing Afrezza in patients aged 4 to 17, with multiple daily insulin ...

Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re one of the millions of adults worldwide who heard about Novo Nordisk’s ...

The landscape of diabetes management is undergoing a remarkable transformation. Groundbreaking research has uncovered surprising cardiovascular benefits tied to modern medications, offering new hope ...

A new study, published in JAMA Neurology, finds that people with type 2 diabetes who take two common anti-diabetes medications had a reduced risk of Alzheimer’s and associated dementias. Specifically, ...

A life-changing treatment that delays the onset of oppressive type 1 diabetes symptoms, and the need for insulin injections, ...

A new and increasingly widely used diabetes medication may have additional health benefits for older adults, according to new research which looked at data from more than 300,000 patients who have ...

In the United States, over 30 million people suffer from diabetes, while nearly 98 million are classified as pre-diabetic. Unfortunately, rather than addressing the fundamental lifestyle factors that ...

Diabetes and Parkinson’s patients are facing drug shortages because of the Iran war, pharmacists have warned. Shortages of several critical medicines have become “considerably worse” over the past two ...

Share on Pinterest A commonly prescribed diabetes medication is emerging as a promising treatment for age-related macular degeneration (AMD). George Pachantouris/Getty Images Researchers say the type ...

Medicare prescription drug coverage, such as stand-alone Part D plans and Medicare Advantage drug plans, provides comprehensive coverage for diabetes medications. Original Medicare (parts A and B) ...

Study results show high treatment discontinuation and low adherence among US adults with painful diabetic peripheral neuropathy.